日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dosimetry and pharmacokinetics of [(177)Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours

[(177)Lu]Lu-沙托瑞肽四西坦在进展性神经内分泌肿瘤患者中的剂量学和药代动力学

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-024-06682-1
Schürrle, Seval Beykan; Eberlein, Uta; Ansquer, Catherine; Beauregard, Jean-Mathieu; Durand-Gasselin, Lucie; Grønbæk, Henning; Haug, Alexander; Hicks, Rodney J; Lenzo, Nat P; Navalkissoor, Shaunak; Nicolas, Guillaume P; Pais, Ben; Volteau, Magali; Wild, Damian; McEwan, Alexander; Lassmann, Michael
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

MIRD Pamphlet No. 30: MIRDfit-A Tool for Fitting of Biodistribution Time-Activity Data for Internal Dosimetry

MIRD 手册第 30 号：MIRDfit——用于拟合生物分布时间-活度数据以进行内剂量测定的工具

期刊:
影响因子:
doi:10.2967/jnumed.124.268011
Carter, Lukas M; Ocampo Ramos, Juan Camilo; Schuerrle, Seval Beykan; Marquis, Harry; Lassmann, Michael; Bolch, Wesley E; Kesner, Adam L
发表日期：2024
文献求助 收藏

Evaluation of the dosimetry approaches in ablation treatment of thyroid cancer

甲状腺癌消融治疗中剂量学方法的评估

期刊:Journal of Applied Clinical Medical Physics
影响因子:2.2
doi:10.1002/acm2.12350
Alan Selcuk, Nalan; Toklu, Turkay; Beykan, Seval; Karaaslan, Serife Ipek
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2018
文献求助 收藏

[(177)Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent

[(177)Lu]pentixather：首个靶向CXCR4的内放射治疗药物的全面临床前表征

期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.19119
Schottelius, Margret; Osl, Theresa; Poschenrieder, Andreas; Hoffmann, Frauke; Beykan, Seval; Hänscheid, Heribert; Schirbel, Andreas; Buck, Andreas K; Kropf, Saskia; Schwaiger, Markus; Keller, Ulrich; Lassmann, Michael; Wester, Hans-Jürgen
CXCR4
发表日期：2017
文献求助 收藏

Synthesis and preclinical evaluation of an Al(18)F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand

Al(18)F放射性氟化GLU-UREA-LYS(AHX)-HBED-CC PSMA配体的合成及临床前评价

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-016-3437-y
Boschi, Stefano; Lee, Jason T; Beykan, Seval; Slavik, Roger; Wei, Liu; Spick, Claudio; Eberlein, Uta; Buck, Andreas K; Lodi, Filippo; Cicoria, Gianfranco; Czernin, Johannes; Lassmann, Michael; Fanti, Stefano; Herrmann, Ken
发表日期：2016
文献求助 收藏

(177)Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model

（177）Lu-OPS201靶向生长抑素受体：猪模型体内生物分布和剂量测定

期刊:Ejnmmi Research
影响因子:3
doi:10.1186/s13550-016-0204-9
Beykan, Seval; Dam, Jan S; Eberlein, Uta; Kaufmann, Jens; Kjærgaard, Benedict; Jødal, Lars; Bouterfa, Hakim; Bejot, Romain; Lassmann, Michael; Jensen, Svend Borup
信号转导
发表日期：2016
文献求助 收藏

The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathy

177Lu-奥曲肽治疗对99mTc-MAG3清除率的影响并不能预测晚期肾病。

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.9775
Werner, Rudolf A; Beykan, Seval; Higuchi, Takahiro; Lückerath, Katharina; Weich, Alexander; Scheurlen, Michael; Bluemel, Christina; Herrmann, Ken; Buck, Andreas K; Lassmann, Michael; Lapa, Constantin; Hänscheid, Heribert
MAG
发表日期：2016
文献求助 收藏

Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy

用于成像和治疗的靶向前列腺特异性膜抗原的探针的生物分布和辐射剂量测定

期刊:
影响因子:
doi:10.2967/jnumed.115.156133
Herrmann, Ken; Bluemel, Christina; Weineisen, Martina; Schottelius, Margret; Wester, Hans-Jürgen; Czernin, Johannes; Eberlein, Uta; Beykan, Seval; Lapa, Constantin; Riedmiller, Hubertus; Krebs, Markus; Kropf, Saskia; Schirbel, Andreas; Buck, Andreas K; Lassmann, Michael
发表日期：2015
文献求助 收藏